Summary
In the pharmacological treatment of bed-wetting, only 2 groups of substances are useful: desmopressin, the antidiuretic hormone analogue and, to some extent, tricyclic antidepressants. Desmopressin appears to decrease nightly urine volumes to levels below bladder capacity and is effective in reducing the severity of enuresis in most patients; however, the long term cure rate is relatively low after withdrawal of the drug. The same is true for the tricyclic antidepressants, but because of their side effects and the potential risk of serious intoxication when overdosing occurs, these drugs are no longer the first choice in the pharmacological treatment of enuresis.
Similar content being viewed by others
References
Aladjem M, Wohl R, Boichis H, Orda S, Lotan D, et al. Desmopressin in nocturnal enuresis. Archives of Disease in Childhood 57: 137–140, 1982
Bakwin H. Enuresis in twins. American Journal of Diseases of Children 121: 222–225, 1971
Becker DJ, Foley TP. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood. Journal of Pediatrics 92: 1011–1018, 1978
Belmaker RH, Belich A. The use of desmopressin in adult enuresis. Military Medicine 151: 660–662, 1986
Bennett HJ. Imipramine and enuresis: never forget its dangers. Pediatrics 69: 831–832, 1982
Birkasova M, Birkas O, Flynn MJ, Cort JH. Desmopressin in the management of nocturnal enuresis in children: a double-blind study. Pediatrics 62: 970–974, 1978
Blackwell B, Currah J. The pharmacology of enuresis. In Kolvin I et al. (Eds) Bladder control and enuresis, pp. 231–257, Lippincott, Philadelphia, 1973
Brook CGD. The physiology of arginine vasopressin. In Meadow SR (Ed.) Desmopressin in nocturnal enuresis: proceedings of an international symposium, pp. 22–25, Major Communications Limited, England, 1989
Delaere KP, Strijbos WE. Antidiuretic approach with DDAVP for nocturnal enuresis. Acta Urologica Belgica 54: 464–470, 1986
Dimson SB. Desmopressin as a treatment for enuresis. Lancet 1: 1260, 1977
Dimson SB. DDAVP and urine osmolarity in refractory enuresis. Archives of Disease in Childhood 61: 1104–1107, 1986
Dische S. Childhood enuresis. Practitioner 221: 323–330, 1978
Evans JHC. The efficacy of DDAVP in the treatment of nocturnal enuresis. In Meadow SR (Ed.) Desmopressin in nocturnal enuresis: proceedings of an international symposium, pp. 29–34, Major Communications Limited, England, 1989
Fergusson DM, Horwood LJ, Shannon FT. Factors related to the age of attainment of nocturnal bladder control: an 8-year-old longitudinal study. Pediatrics 78: 884–890, 1986
Fjellestad-Paulsen A, Willie S, Harris AS. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Archives of Disease in Childhood 62: 67–47, 1987
Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretics. Archives of Disease in Childhood 49: 259, 1974
Foxman B, Valdez RB, Brook RH. Childhood enuresis: prevalence, perceived impact and prescribed treatments. Pediatrics 77: 482–487, 1986
Hammer M, Vilhardt H. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. Journal of Pharmacology and Experimental Therapeutics 234: 754–760, 1985
Holt J, Borresen B. Enuresis is noctural in school children in Bodö. A therapeutic trial with a vasopressin analogue: desmopressin and imipramine, Tidsskrift foer den Norske Laegeförening 106: 651–654, 1986
Kardash S, Hillman ES, Werry J. Efficacy of imipramine in childhood enuresis: a double-blind control study with placebo. Canadian Medical Association Journal 99: 263–266, 1968
Klauber GT. Clinical efficacy and safety of desmopressin in the treatment of nocturnal enuresis. Journal of Pediatrics 4: 719–722, 1989
Lehotska V, Lichardus B, Nemethova V. Application of 1-deamino-8-D-arginine vasopressin (DDAVP) in symptomatic treatment of nocturnal enuresis. Bratislavske Lekarske Listy 72: 670–676, 1979
Lenoir G, Barthelemy J, Juit-Bielsky MC. Bed-wetting therapy. Pediatrics 79: 1056, 1987
Meadow SR. Management of nocturnal enuresis. In Meadow SR (Ed.) Desmopressin in nocturnal enuresis: proceedings of an internalional symposium, pp. 16–30, Major Communications Limited, England, 1989
Mikkelson EJ, Rapoport JL. Enuresis: psychopathology, sleep stage and drug response. Urology Clinics of North America 7: 361, 1980
Miller K, Goldberg S, Atkin B. Nocturnal enuresis: experience with long-term use of intranasally administrated desmopressin. Journal of Pediatrics 4: 723–726, 1989
Nörgaard JP. Urodynamics in enuretics. I. Neurology and Urodynamics 8: 199–211, 1989a
Nörgaard JP. Urodynamics in enuretics. II. Neurology and Urodynamics 8: 213–217, 1989b
Nörgaard JP, Rittig S. Recent studies of the pathophysiology of nocturnal enuresis. In Meadow SR (Ed.) Desmopressin in nocturnal enuresis: proceedings of an international symposium, pp. 11–14, Major Communications Limited, England, 1989
Novello AC, Novello JR. Enuresis. Pediatric Nephrology 34: 719–733, 1987
Palmisano PA. Enuresis: causes, cures and cautions. Western Journal of Medicine 125: 347–349, 1976
Pedersen PS, Hejl M, Kjøller SS. Desamino-D-arginine vasopressin in childhood nocturnal enuresis. Journal of Urology 133: 65–66, 1985
Post EM, Richmas RA, Blackett PR, Duncan KP, Miller K. Desmopressin response of enuretic children: effects on age and frequency of enuresis. American Journal of Diseases of Children 137: 962–963, 1983
Poussaint AF, Ditman KS. A controlled study of imipramine in the treatment of childhood enuresis. Journal of Pediatrics 67: 283, 1965
Puri VN. Increased urinary antidiuretic hormone excretion by imipramine. Experimental Clinical Endocrinology 88: 112–114, 1986
Ramsden PD, Hindmarsh JR, Price DA, Yeates WK, Bowditch JD. DDAVP for adult enuresis — a preliminary report. British Journal of Urology 54: 256–258, 1982
Rew D, Rundle J. Assessment of the safety of regular DDAVP therapy in primary nocturnal enuresis. British Journal of Urology 63: 352–353, 1989
Rittig S, Knudsen UB, Sörensen S, Djurhuus JC, Nörgaard JP. Long-term double-blind cross-over study of desmopressin intranasal spray in the management of nocturnal enuresis. In Meadow SR (Ed.) Desmopressin in nocturnal enuresis. Proceedings of an international symposium, pp. 43-54, London, 1989
Shelov SP, Gundy J, Weiss JC, et al. Ambulatory Pediatric Association Collaborative Research Workshop: Enuresis — a contrast of attitudes of parents and physicians. Pediatrics 67: 707, 1981
Simmonds EJ, Mahoney MJ, Littlewood JM. Convulsion and coma after intranasal DDAVP in cystic fibrosis. British Medical Journal 297: 1614, 1988
Sukhai RN, Mol J, Harris AS. Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis. European Journal of Pediatrics 148: 465–467, 1989
Terho P, Kekomaki M. Management of nocturnal enuresis with a vasopressin analogue. Journal of Urology 131: 925–927, 1984
Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Paediatrica Scandinavica 67: 753–755, 1978
Vilhardt H, Lundin S, Falch J. Plasma kinetics of DDAVP in man. Acta Pharmacologica et Toxicologica 58: 379, 1986
Wille S. Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Archives of Disease in Childhood 61: 30–33, 1986
Yurdakök M, Kinik E, Beduk Y, Guveng H, Us Ö. Treatment of enuresis: a study with imipramine, amitriptyline, chlordiazepoxide-clidinium and piracetam. Turkish Journal of Pediatrics 28: 171–175, 1986
Zaoral M, Kolcj J, Sorm F. College of Czechoslovak Chemical Communications 32: 1250, 1967
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hjälmås, K., Sillén, U. Pharmacological Treatment of Bed-Wetting. Drug Invest 2 (Suppl 5), 17–21 (1990). https://doi.org/10.1007/BF03258237
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258237